A detailed history of Annex Advisory Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Annex Advisory Services, LLC holds 63,010 shares of ABBV stock, worth $11.3 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
63,010
Previous 64,956 3.0%
Holding current value
$11.3 Million
Previous $11.1 Million 11.69%
% of portfolio
0.45%
Previous 0.41%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$163.84 - $199.33 $318,832 - $387,896
-1,946 Reduced 3.0%
63,010 $12.4 Million
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $167,173 - $195,220
1,080 Added 1.69%
64,956 $11.1 Million
Q1 2024

Apr 12, 2024

SELL
$159.82 - $182.1 $209,843 - $239,097
-1,313 Reduced 2.01%
63,876 $11.6 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $278,502 - $313,659
-2,024 Reduced 3.01%
65,189 $10.1 Million
Q3 2023

Oct 31, 2023

BUY
$133.59 - $154.65 $60,649 - $70,211
454 Added 0.68%
67,213 $10 Million
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $9.66 Million - $12 Million
-72,919 Reduced 52.21%
66,759 $8.99 Million
Q1 2023

Apr 27, 2023

SELL
$144.61 - $166.54 $319,877 - $368,386
-2,212 Reduced 1.56%
139,678 $22.3 Million
Q4 2022

Jan 27, 2023

SELL
$138.31 - $165.87 $126,277 - $151,439
-913 Reduced 0.64%
141,890 $22.9 Million
Q3 2022

Oct 24, 2022

SELL
$134.21 - $153.93 $585,021 - $670,980
-4,359 Reduced 2.96%
142,803 $19.2 Million
Q2 2022

Jul 27, 2022

SELL
$137.62 - $174.96 $1.59 Million - $2.03 Million
-11,580 Reduced 7.29%
147,162 $22.5 Million
Q1 2022

Apr 13, 2022

SELL
$131.98 - $163.75 $170,122 - $211,073
-1,289 Reduced 0.81%
158,742 $25.7 Million
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $938,938 - $1.19 Million
8,740 Added 5.78%
160,031 $21.7 Million
Q3 2021

Oct 18, 2021

BUY
$106.4 - $120.78 $1.97 Million - $2.24 Million
18,521 Added 13.95%
151,291 $16.3 Million
Q2 2021

Jul 29, 2021

BUY
$105.21 - $117.21 $1.65 Million - $1.84 Million
15,656 Added 13.37%
132,770 $15 Million
Q1 2021

Apr 22, 2021

BUY
$102.3 - $112.62 $408,893 - $450,142
3,997 Added 3.53%
117,114 $12.7 Million
Q4 2020

Jan 28, 2021

BUY
$80.49 - $108.67 $3.91 Million - $5.28 Million
48,590 Added 75.3%
113,117 $12.1 Million
Q3 2020

Oct 23, 2020

BUY
$85.91 - $100.83 $130,153 - $152,757
1,515 Added 2.4%
64,527 $5.65 Million
Q2 2020

Jul 21, 2020

BUY
$73.37 - $98.18 $226,639 - $303,278
3,089 Added 5.15%
63,012 $6.19 Million
Q1 2020

Apr 22, 2020

BUY
$64.5 - $97.79 $2.68 Million - $4.06 Million
41,503 Added 225.31%
59,923 $4.57 Million
Q4 2019

Feb 10, 2020

SELL
$72.13 - $90.25 $24,091 - $30,143
-334 Reduced 1.78%
18,420 $1.63 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $26,703 - $32,105
424 Added 2.31%
18,754 $1.42 Million
Q2 2019

Jul 18, 2019

SELL
$65.7 - $83.98 $56,239 - $71,886
-856 Reduced 4.46%
18,330 $1.33 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $2.28 Million - $2.68 Million
-29,517 Reduced 60.61%
19,186 $1.55 Million
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $57,375 - $70,759
737 Added 1.54%
48,703 $4.49 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $196,757 - $218,732
2,213 Added 4.84%
47,966 $4.54 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $152,356 - $180,272
1,697 Added 3.85%
45,753 $4.24 Million
Q1 2018

May 03, 2018

BUY
$92.01 - $123.21 $70,755 - $94,748
769 Added 1.78%
44,056 $4.17 Million
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $42,809 - $46,944
478 Added 1.12%
43,287 $4.19 Million
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $2.99 Million - $3.82 Million
42,809
42,809 $3.8 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Annex Advisory Services, LLC Portfolio

Follow Annex Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annex Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annex Advisory Services, LLC with notifications on news.